Ascend Wellness Holdings PE Ratio 2020-2024 | AAWH
Current and historical p/e ratio for Ascend Wellness Holdings (AAWH) from 2020 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Ascend Wellness Holdings PE ratio as of May 13, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Ascend Wellness Holdings PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2025-05-09 | 0.37 | 0.00 | |
2024-12-31 | 0.39 | $-0.40 | 0.00 |
2024-09-30 | 0.83 | $-0.41 | 0.00 |
2024-06-30 | 0.91 | $-0.33 | 0.00 |
2024-03-31 | 1.30 | $-0.23 | 0.00 |
2023-12-31 | 1.00 | $-0.24 | 0.00 |
2023-09-30 | 0.94 | $-0.23 | 0.00 |
2023-06-30 | 0.62 | $-0.27 | 0.00 |
2023-03-31 | 0.95 | $-0.38 | 0.00 |
2022-12-31 | 1.15 | $-0.44 | 0.00 |
2022-09-30 | 1.82 | $-0.46 | 0.00 |
2022-06-30 | 1.92 | $-0.45 | 0.00 |
2022-03-31 | 4.00 | $-0.34 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.076B | $0.562B |
Ascend Wellness Holdings Inc. is a vertically integrated multi-state cannabis operator focused on bettering lives through cannabis. Ascend Wellness Holdings Inc. is based in NEW YORK. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $143.728B | 26.96 |
Elevance Health (ELV) | United States | $94.145B | 12.15 |
CVS Health (CVS) | United States | $81.986B | 10.19 |
Cencora (COR) | United States | $53.983B | 18.77 |
Natera (NTRA) | United States | $21.477B | 0.00 |
DiDi Global (DIDIY) | China | $21.462B | 32.57 |
BioMerieux (BMXMF) | France | $15.263B | 0.00 |
Solventum (SOLV) | United States | $12.941B | 13.70 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.036B | 0.00 |
Revvity (RVTY) | United States | $11.610B | 19.98 |
Doximity (DOCS) | United States | $11.396B | 59.26 |
ICON (ICLR) | Ireland | $11.324B | 10.53 |
CochLear (CHEOY) | Australia | $11.195B | 0.00 |
Viatris (VTRS) | United States | $10.516B | 3.61 |
Medpace Holdings (MEDP) | United States | $9.017B | 23.95 |
Avantor (AVTR) | United States | $8.859B | 12.87 |
HealthEquity (HQY) | United States | $8.361B | 41.13 |
Sonic Healthcare (SKHHY) | Australia | $8.215B | 0.00 |
Charles River Laboratories (CRL) | United States | $7.027B | 13.77 |
Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
Bausch + Lomb (BLCO) | Canada | $4.202B | 24.77 |
BrightSpring Health Services (BTSG) | United States | $3.894B | 36.05 |
Sotera Health (SHC) | United States | $3.832B | 21.77 |
Surgery Partners (SGRY) | United States | $2.982B | 38.77 |
Alignment Healthcare (ALHC) | United States | $2.952B | 0.00 |
Concentras Parent (CON) | United States | $2.771B | 16.01 |
Organon (OGN) | United States | $2.264B | 2.41 |
Ardent Health Partners (ARDT) | United States | $2.121B | 9.04 |
Premier (PINC) | United States | $2.101B | 14.38 |
Progyny (PGNY) | United States | $1.886B | 41.51 |
PACS (PACS) | United States | $1.698B | 0.00 |
GeneDx Holdings (WGS) | United States | $1.683B | 64.83 |
GoodRx Holdings (GDRX) | United States | $1.669B | 31.07 |
Teladoc Health (TDOC) | United States | $1.289B | 0.00 |
Pediatrix Medical (MD) | United States | $1.234B | 9.39 |
Agilon Health (AGL) | United States | $1.229B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.000B | 0.00 | |
Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
CareDx (CDNA) | United States | $0.911B | 14.23 |
AMN Healthcare Services Inc (AMN) | United States | $0.866B | 8.11 |
Embecta (EMBC) | United States | $0.725B | 4.89 |
QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
Nutex Health (NUTX) | United States | $0.689B | 13.50 |
Enhabit (EHAB) | United States | $0.530B | 43.58 |
InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.513B | 13.59 |
Sonida Senior Living (SNDA) | United States | $0.512B | 0.00 |
LifeMD (LFMD) | United States | $0.389B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
SBC Medicals (SBC) | United States | $0.359B | 0.00 |
Beauty Health (SKIN) | United States | $0.220B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.202B | 0.00 |
Oncology Institute (TOI) | United States | $0.193B | 0.00 |
DocGo (DCGO) | United States | $0.147B | 24.08 |
Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
So-Young (SY) | China | $0.087B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
KindlyMD (KDLY) | United States | $0.082B | 0.00 |
OncoCyte (OCX) | United States | $0.080B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
Biodesix (BDSX) | United States | $0.053B | 0.00 |
Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
ModivCare (MODV) | United States | $0.018B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |